ID
23263
Beschrijving
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus
Trefwoorden
Versies (1)
- 01-07-17 01-07-17 -
Houder van rechten
Genentech, Inc.
Geüploaded op
1 juli 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
STUDY COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED) CRFs Roche FVF4170G Macular Edema NCT00473382
STUDY COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED) CRFs Roche FVF4170G Macular Edema NCT00473382
Beschrijving
STUDY COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED)
Beschrijving
DISC_COMPLETED_STUDY [DCCMP]
Datatype
integer
Alias
- UMLS CUI [1]
- C2826674
Beschrijving
DISC_COMP_DT [DCCDT]
Datatype
date
Maateenheden
- DD/MMM/YY
Alias
- UMLS CUI [1]
- C2983670
Beschrijving
DISC_PRIMARY_REASON [DCRS]
Datatype
integer
Alias
- UMLS CUI [1,1]
- C2348571
- UMLS CUI [1,2]
- C0566251
Beschrijving
DISC_PRIMARY_REAS_SP [DCRSP]
Datatype
text
Alias
- UMLS CUI [1,1]
- C2348571
- UMLS CUI [1,2]
- C0566251
- UMLS CUI [1,3]
- C0184661
Similar models
STUDY COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED) CRFs Roche FVF4170G Macular Edema NCT00473382
C2986440 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
C0184661 (UMLS CUI [1,3])